The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

GSK GLAXOSMITHKLINE PLC ORD 25P



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  28392.00 27387.00 26431.00 26505.00 23006.00
Operating Profit/(Loss)  3783.00 7807.00 7300.00 7028.00 3597.00
Net Interest  767.00 744.00 745.00 726.00 688.00
Profit Before Tax  3157.00 7698.00 6600.00 6647.00 2968.00
Profit After Tax  1853.00 5458.00 4678.00 5628.00 2831.00
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  1853.00 5458.00 4678.00 5628.00 2831.00
Attributable to:
Minority Interests  -219.00 -197.00 -179.00 -192.00 -75.00
Equity Holders of Parent Company  1634.00 5261.00 4499.00 5436.00 2756.00
 
Continuing EPS
Earnings per Share - Basic  32.10p 104.60p 91.60p 112.50p 57.30p
Earnings per Share - Diluted  31.90p 103.20p 90.20p 110.50p 56.70p
Earnings per Share - Adjusted  53.90p 104.60p 111.40p 108.40p 95.40p
Continuing and Discontinued EPS
Earnings per Share - Basic  32.10p 104.60p 91.60p 112.50p 57.30p
Earnings per Share - Diluted  31.90p 103.20p 90.20p 110.50p 56.70p
Earnings per Share - Adjusted  53.90p 104.60p 111.40p 108.40p 95.40p
 
Dividend per Share  63.00p 67.00p 72.00p 76.00p 80.00p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  6873.00 6656.00 6835.00 6355.00 5983.00
Intangible Assets  12138.00 11556.00 14520.00 13488.00 12044.00
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  1792.00 1150.00 1366.00 1525.00 1454.00
Other Financial Assets  97.00 85.00 54.00 1.00 0.00
Other Non-Current Assets  5294.00 5466.00 5014.00 5490.00 6492.00
  26194.00 24913.00 27789.00 26859.00 25973.00
Current Assets
Inventories  3837.00 3873.00 3969.00 3900.00 4231.00
Trade & Other Receivables  5849.00 5661.00 5345.00 5571.00 4738.00
Cash at Bank & in Hand  6057.00 5714.00 4184.00 5534.00 4338.00
Current Asset Investments  277.00 254.00 130.00 221.00 215.00
Other Current Assets  16.00 665.00 64.00 1.00 1156.00
  16036.00 16167.00 13692.00 15227.00 14678.00
 
Total Assets  42230.00 41080.00 41481.00 42086.00 40651.00
 
Liabilities
Current Liabilities
Borrowings  -291.00 -2698.00 -3631.00 -2789.00 -2943.00
Other Current Liabilities  -12503.00 -12312.00 -10184.00 -10888.00 -10352.00
  -12794.00 -15010.00 -13815.00 -13677.00 -13295.00
 
Net Current Assets  3242.00 1157.00 -123.00 1550.00 1383.00
 
Non-Current Liabilities
Borrowings  -14809.00 -12203.00 -14671.00 -15456.00 -15841.00
Provisions  -1611.00 -1321.00 -1703.00 -1245.00 -990.00
Other Non-Current Liabilities  -3271.00 -3719.00 -4555.00 -3896.00 -5589.00
  -19691.00 -17243.00 -20929.00 -20597.00 -22420.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -32485.00 -32253.00 -34744.00 -34274.00 -35715.00
 
Net Assets  9745.00 8827.00 6737.00 7812.00 4936.00
 
Capital & Reserves
Share Capital  1418.00 1387.00 1349.00 1336.00 1339.00
Share Premium Account  1428.00 1673.00 2022.00 2595.00 2759.00
Other Reserves  1262.00 1602.00 1787.00 2153.00 2239.00
Retained Earnings  4779.00 3370.00 642.00 913.00 -2074.00
Shareholders Funds  8887.00 8032.00 5800.00 6997.00 4263.00
 
Minority Interests/Other Equity  858.00 795.00 937.00 815.00 673.00
Total Equity  9745.00 8827.00 6737.00 7812.00 4936.00

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  23.01 14.07 11.98 14.87 14.42
PEG - Adjusted  -0.41 0.15 1.84 -5.53 -1.20
Earnings per Share Growth - Adjusted  -55.53% 94.06% 6.50% -2.69% -11.99%
Dividend Cover  0.86 1.56 1.55 1.43 1.19
Revenue Per Share  558.35p 544.69p 538.09p 548.64p 478.49p
Pre-Tax Profit per Share  62.08p 153.10p 134.36p 137.59p 61.73p
Operating Margin  12.24% 30.83% 27.45% 28.34% 20.22%
Return on Capital Employed  23.10% 50.90% 47.87% 46.07% 23.07%
 
Continuing & Discontinued Operations
Dividend Yield  5.08% 4.55% 5.39% 4.72% 5.81%
Dividend per Share Growth  6.78% 6.35% 7.46% 5.56% 5.26%
Net Asset Value per Share (exc. Intangibles)  -62.56p -69.80p -177.86p -133.70p -159.98p
Net Gearing  101.76% 114.38% 243.41% 181.66% 338.87%

Data is provided by Morningstar


Company Information
Updated Monthly
Company address C8 Gsk House, 980 Great West Road, Brentford, TW8 9GS, United Kingdom
Company website http://www.gsk.com
Market cap(in millions)* £ 65,511.95
Listing/Admission to trading 22 May 1972
Trading service -
Market -
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
05-Jul-15
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



GLAXOSMITHKLINE share - fundamentals